Esther Salgueiro

599 total citations
30 papers, 396 citations indexed

About

Esther Salgueiro is a scholar working on Toxicology, Pharmacology and Geriatrics and Gerontology. According to data from OpenAlex, Esther Salgueiro has authored 30 papers receiving a total of 396 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Toxicology, 8 papers in Pharmacology and 8 papers in Geriatrics and Gerontology. Recurrent topics in Esther Salgueiro's work include Pharmacovigilance and Adverse Drug Reactions (10 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Pharmaceutical studies and practices (6 papers). Esther Salgueiro is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (10 papers), Pharmaceutical Practices and Patient Outcomes (8 papers) and Pharmaceutical studies and practices (6 papers). Esther Salgueiro collaborates with scholars based in Spain and Poland. Esther Salgueiro's co-authors include Gloria Manso, Luis H. Martín Arias, Agustı́n Hidalgo, María Sáinz-Gil, Teresa Rubio, M. Isabel Lucena, Raúl J. Andrade, Víctor M. González, José María Duque and E. Gómez and has published in prestigious journals such as SHILAP Revista de lepidopterología, Vaccine and Maturitas.

In The Last Decade

Esther Salgueiro

29 papers receiving 379 citations

Peers

Esther Salgueiro
Katja S. Just Germany
Jérémy Jové France
Ryuichi Ogawa Japan
Rima Shah India
Alexandra E. Rätz Bravo Switzerland
Yannick Arimone France
Egı́dio Lima Dórea Brazil
Ariola Koci Italy
Natsumi Ueda Japan
Claudia B. Karwoski United States
Katja S. Just Germany
Esther Salgueiro
Citations per year, relative to Esther Salgueiro Esther Salgueiro (= 1×) peers Katja S. Just

Countries citing papers authored by Esther Salgueiro

Since Specialization
Citations

This map shows the geographic impact of Esther Salgueiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Esther Salgueiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Esther Salgueiro more than expected).

Fields of papers citing papers by Esther Salgueiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Esther Salgueiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Esther Salgueiro. The network helps show where Esther Salgueiro may publish in the future.

Co-authorship network of co-authors of Esther Salgueiro

This figure shows the co-authorship network connecting the top 25 collaborators of Esther Salgueiro. A scholar is included among the top collaborators of Esther Salgueiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Esther Salgueiro. Esther Salgueiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Galache, Cristina, Esther Salgueiro, Javier Bordallo, et al.. (2022). Retrospective study of apremilast drug survival in psoriasis patients in a daily practice setting: A long‐term experience. Dermatologic Therapy. 35(7). e15583–e15583. 2 indexed citations
3.
Manso, Gloria, et al.. (2019). Medicines under additional monitoring in the European Union.. SHILAP Revista de lepidopterología. 43(1). 19–23. 1 indexed citations
4.
Fierro, Inmaculada, et al.. (2019). A cross-sectional study of psychotropic drug use in the elderly: Consuming patterns, risk factors and potentially inappropriate use. European Journal of Hospital Pharmacy. 28(2). 88–93. 5 indexed citations
5.
Arias, Luis H. Martín, et al.. (2018). Cardiovascular and gastrointestinal safety of selective cyclooxygenase-2 inhibitors: a case/non-case study. International Journal of Clinical Pharmacy. 40(4). 928–935. 5 indexed citations
6.
Salgueiro, Esther, et al.. (2018). Los criterios STOPP/START más frecuentes en España. Una revisión de la literatura. Revista Española de Geriatría y Gerontología. 53(5). 274–278. 13 indexed citations
7.
Arias, Luis H. Martín, et al.. (2018). Gastrointestinal safety of coxibs: systematic review and meta‐analysis of observational studies on selective inhibitors of cyclo‐oxygenase 2. Fundamental and Clinical Pharmacology. 33(2). 134–147. 9 indexed citations
8.
Arias, Luis H. Martín, et al.. (2017). Risk of bursitis and other injuries and dysfunctions of the shoulder following vaccinations. Vaccine. 35(37). 4870–4876. 48 indexed citations
9.
Salgueiro, Esther, et al.. (2016). Beers versus STOPP criteria in polyharmacy community-dwelling older patients.. PubMed. 40(3). 150–64. 9 indexed citations
10.
Salgueiro, Esther, et al.. (2016). Inappropriate prescribing in elderly outpatients taking multiple medications. Are the STOPP criteria useful?. International Journal of Clinical Pharmacology and Therapeutics. 54(3). 172–176. 6 indexed citations
11.
Salgueiro, Esther, et al.. (2015). Spontaneous reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with antiepileptic drugs.. PubMed. 19(14). 2732–7. 23 indexed citations
12.
Salgueiro, Esther, et al.. (2015). Optimización de la información sobre la medicación de personas polimedicadas en atención primaria. Gaceta Sanitaria. 30(1). 69–72. 5 indexed citations
13.
Salgueiro, Esther, et al.. (2012). Farmacovigilancia y errores de medicación. Revista ROL de enfermería. 35(3). 8–18. 1 indexed citations
14.
Salgueiro, Esther, Gloria Manso, Xavier Castells, et al.. (2012). Trends in the pharmacological treatment of osteoporosis in Spain from 2000 to 2008. Maturitas. 74(1). 74–78. 9 indexed citations
15.
Santos‐Juanes, Jorge, et al.. (2011). Acute Renal Failure Caused by Imiquimod 5% Cream in a Renal Transplant Patient: Review of the Literature on Side Effects of Imiquimod. Dermatology. 222(2). 109–112. 19 indexed citations
16.
Salgueiro, Esther, et al.. (2010). Relevancia clínica de las notificaciones de reacciones adversas de atención primaria recibidas en el centro de farmacovigilancia de Asturias. Medicina de Familia SEMERGEN. 36(2). 63–68. 2 indexed citations
17.
González, Víctor M., et al.. (2008). Post‐marketing safety of antineoplasic monoclonal antibodies: rituximab and trastuzumab. Pharmacoepidemiology and Drug Safety. 17(7). 714–721. 21 indexed citations
18.
Manso, Gloria, et al.. (2005). Spontaneous reporting of hepatotoxicity associated with antiandrogens: data from the Spanish pharmacovigilance system. Pharmacoepidemiology and Drug Safety. 15(4). 253–259. 31 indexed citations
19.
Manso, Gloria, et al.. (2004). Hepatotoxicity Induced by Antiandrogens: A Review of the Literature. Urologia Internationalis. 73(4). 289–295. 61 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katja S. Just Breakdown of academic impact, for papers by Jérémy Jové Breakdown of academic impact, for papers by Ryuichi Ogawa Breakdown of academic impact, for papers by Rima Shah Breakdown of academic impact, for papers by Alexandra E. Rätz Bravo Breakdown of academic impact, for papers by Yannick Arimone Breakdown of academic impact, for papers by Egı́dio Lima Dórea Breakdown of academic impact, for papers by Ariola Koci Breakdown of academic impact, for papers by Natsumi Ueda Breakdown of academic impact, for papers by Claudia B. Karwoski
Rankless by CCL
2026